Related Experiment Video
Updated: May 20, 2026
09:31
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
New roads open up for implementing immunotherapy in mesothelioma
R Cornelissen1, M E Heuvers, A P Maat
1Department of Pulmonary Medicine, Erasmus Medical Center-Daniel den Hoed Cancer Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. r.cornelissen@erasmusmc.nl
Clinical & Developmental Immunology
|July 11, 2012
Summary
Malignant mesothelioma treatment is limited. Immunotherapy combined with targeting tumor cells may offer a superior approach by overcoming immune evasion strategies within the tumor microenvironment.
Area of Science:
- Oncology
- Immunology
Background:
- Malignant mesothelioma has limited effective treatment options, with conventional therapies offering only modest survival benefits.
- Chronic inflammation is linked to mesothelioma development, highlighting the immune system's role in tumorigenesis.
- Mesothelioma cells can evade immune surveillance by creating a protective tumor microenvironment that suppresses anti-tumor responses.
Purpose of the Study:
- To explore the potential of combining immunomodulatory strategies with direct tumor cell targeting for malignant mesothelioma.
- To discuss the challenges posed by the tumor microenvironment in developing effective immunotherapies.
- To identify potential strategies for overcoming these challenges and improving treatment outcomes.
Main Methods:
- Review of existing literature on mesothelioma pathogenesis and immune system interactions.
- Analysis of the tumor microenvironment's role in immune evasion.
- Discussion of current and potential immunotherapy approaches.
Main Results:
- Conventional chemotherapy provides limited survival improvement for mesothelioma patients.
- The tumor microenvironment actively suppresses anti-tumor immunity, presenting a significant therapeutic hurdle.
- Immunotherapy strategies face challenges due to the complex interplay of immune cells within the tumor.
Conclusions:
- Simultaneous modulation of the immune system and targeting of mesothelioma cells presents a promising therapeutic avenue.
- Overcoming the immune-suppressive tumor microenvironment is critical for successful immunotherapy.
- Further research into novel strategies is needed to harness the immune system against malignant mesothelioma.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...